Analytical Data
-
Gene name
BVES
- Application
-
Alternative Names
BVES；POP1；POPDC1；Blood vessel epicardial substance
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NE79
-
Expression Region
1-360aa
-
AA Sequence
MNYTESSPLRESTAIGFTPELESIIPVPSNKTTCENWREIHHLVFHVANICFAVGLVIPTTLHLHMIFLRGMLTLGCTLYIVWATLYRCALDIMIWNSVFLGVNILHLSYLLYKKRPVKIEKELSGMYRRLFEPLRVPPDLFRRLTGQFCMIQTLKKGQTYAAEDKTSVDDRLSILLKGKMKVSYRGHFLHNIYPCAFIDSPEFRSTQMHKGEKFQVTIIADDNCRFLCWSRERLTYFLESEPFLYEIFRYLIGKDITNKLYSLNDPTLNDKKAKKLEHQLSLCTQISMLEMRNSIASSSDSDDGLHQFLRGTSSMSSLHVSSPHQRASAKMKPIEEGAEDDDDVFEPASPNTLKVHQLP
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Bouquet Virus-Encoded Serine Proteins (BVES) are integral components involved in various cellular processes, particularly in signaling pathways and synaptic functions. Research on BVES has gained momentum due to its vital role in neuron development and its implication in several neurological disorders. Recent findings suggest that BVES acts as a protective factor in neural tissues, modulating responses to stress and inflammation. The understanding of BVES's structure and function has been significantly advanced through recombinant protein studies, allowing researchers to explore its interactions with other cellular components. Recombinant BVES proteins have been synthesized to uncover their biochemical properties and to dissect their roles in cellular mechanisms. These studies have also illuminated how alterations in BVES expression may contribute to pathologies such as epilepsy, neurodegenerative disorders, and even some psychiatric conditions. As BVES demonstrates potential as a therapeutic target, ongoing research aims to delineate its precise mechanisms in cellular signaling, ultimately paving the way for innovative treatments for various neurological diseases. This multidimensional approach to understanding BVES not only enhances our fundamental knowledge of neuronal biology but also underscores the potential for translating these insights into clinical applications.
